Free Trial

Maximus, Inc. (NYSE:MMS) Shares Sold by Charles Schwab Investment Management Inc.

Maximus logo with Business Services background

Key Points

  • Charles Schwab Investment Management Inc. decreased its holdings in Maximus, Inc. by 6.6%, selling 65,558 shares, and now owns approximately 1.65% of the company valued at $63.76 million.
  • Maximus reported a quarterly EPS of $2.16, significantly beating the consensus estimate of $1.39, along with a year-over-year revenue increase of 2.5% to $1.35 billion.
  • The company announced a quarterly dividend of $0.30, yielding 1.4%, with a payout ratio of 22.10%, to be paid on August 31st to shareholders of record on August 15th.
  • Want stock alerts on Maximus? Get 5 Weeks of MarketBeat All Access for $5. Get My Stock Alerts.

Charles Schwab Investment Management Inc. cut its holdings in Maximus, Inc. (NYSE:MMS - Free Report) by 6.6% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 935,106 shares of the health services provider's stock after selling 65,558 shares during the quarter. Charles Schwab Investment Management Inc. owned 1.65% of Maximus worth $63,765,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. UMB Bank n.a. raised its stake in Maximus by 70.2% during the 1st quarter. UMB Bank n.a. now owns 606 shares of the health services provider's stock valued at $41,000 after buying an additional 250 shares during the last quarter. GAMMA Investing LLC increased its stake in Maximus by 67.1% in the 1st quarter. GAMMA Investing LLC now owns 732 shares of the health services provider's stock worth $50,000 after buying an additional 294 shares in the last quarter. NBC Securities Inc. increased its stake in Maximus by 114,900.0% in the 1st quarter. NBC Securities Inc. now owns 1,150 shares of the health services provider's stock worth $78,000 after buying an additional 1,149 shares in the last quarter. Blue Trust Inc. boosted its holdings in shares of Maximus by 32.8% during the 1st quarter. Blue Trust Inc. now owns 1,228 shares of the health services provider's stock valued at $84,000 after purchasing an additional 303 shares during the last quarter. Finally, LRI Investments LLC boosted its holdings in shares of Maximus by 44.1% during the 4th quarter. LRI Investments LLC now owns 1,638 shares of the health services provider's stock valued at $122,000 after purchasing an additional 501 shares during the last quarter. 97.21% of the stock is owned by institutional investors.

Insider Transactions at Maximus

In other Maximus news, Director Gayathri Rajan sold 7,913 shares of Maximus stock in a transaction on Friday, May 30th. The shares were sold at an average price of $72.38, for a total value of $572,742.94. Following the transaction, the director directly owned 14,205 shares of the company's stock, valued at approximately $1,028,157.90. The trade was a 35.78% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 1.60% of the company's stock.

Maximus Trading Down 0.2%

Shares of NYSE:MMS traded down $0.18 during trading on Friday, reaching $84.31. 625,861 shares of the company were exchanged, compared to its average volume of 619,817. The firm has a market capitalization of $4.75 billion, a PE ratio of 15.53 and a beta of 0.60. The business's fifty day simple moving average is $73.03 and its 200-day simple moving average is $70.70. Maximus, Inc. has a 12-month low of $63.77 and a 12-month high of $93.94. The company has a debt-to-equity ratio of 0.91, a current ratio of 2.27 and a quick ratio of 2.27.

Maximus (NYSE:MMS - Get Free Report) last announced its earnings results on Thursday, August 7th. The health services provider reported $2.16 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.39 by $0.77. Maximus had a return on equity of 24.44% and a net margin of 5.83%. The business had revenue of $1.35 billion for the quarter, compared to analysts' expectations of $1.29 billion. During the same quarter last year, the firm earned $1.74 EPS. The business's revenue for the quarter was up 2.5% on a year-over-year basis. On average, research analysts anticipate that Maximus, Inc. will post 6.15 EPS for the current year.

Maximus Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Sunday, August 31st. Shareholders of record on Friday, August 15th will be issued a $0.30 dividend. This represents a $1.20 annualized dividend and a yield of 1.4%. The ex-dividend date of this dividend is Friday, August 15th. Maximus's payout ratio is currently 22.10%.

Analysts Set New Price Targets

Separately, Wall Street Zen downgraded shares of Maximus from a "buy" rating to a "hold" rating in a report on Thursday, May 15th.

Check Out Our Latest Stock Report on MMS

Maximus Company Profile

(Free Report)

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.

Recommended Stories

Institutional Ownership by Quarter for Maximus (NYSE:MMS)

Should You Invest $1,000 in Maximus Right Now?

Before you consider Maximus, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.

While Maximus currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir’s Soaring Valuation—Justified or Overhyped?
3 Stocks With Explosive Upside
September Slowdown: 3 Stocks to Buy When the Pullback Comes

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines